BioE PhD students Sally Winkler and Kayla Wolf are receiving a 2018 Women In Technology Initiative Athena Award for Next Generation Engagement, for Double Shelix, their podcast all about women in STEM, the grad school grind, and inclusive science. MTM alumna Maria Artunduaga will receive the Early Career Athena Award for work on her startup, Respira Labs.
Alumnus Eric Steen, PhD 2010, is the CEO and co-founder of Lygos Biotech and winner of the Berkeley Chamber of Commerce’s Visionary of the Year award for 2018. The awards go annually to innovators with “imagination and persistence” who live or work in Berkeley.
BioE and EnviroE grad students Andrew Bremer and Sara Glade will tell you.
Published this week in Nature Public Journals: Digital Medicine, Professor Mohammad Mofrad’s lab introduces “Deep Echocardiography” by applying deep learning towards clinical classifications and diagnostics of cardiac diseases.
Visitors from the US House and Senate Labor, Health and Human Services visited UC Berkeley on Tuesday, October 16 and toured Professor Amy Herr’s laboratory. The appropriations staff met with several bioengineering graduate students, as well as Professor Herr, who were able to provide specific stories of NIH funding impact on both research and the […]
Prof Niren Murthy’s lab, led by postdoc Tara deBoer, has developed a new cheap and simple point-of-care assay for diagnosing bacterial drug resistance. Termed DETECT, the technology can identify bacterial drug resistance directly from patient urine samples. The study appears on the Oct. 18 cover of the journal ChemBioChem.
Phd alumnus Ovijit Chaudhuri, now a professor of mechanical engineering at Stanford University, has uncovered a previously unknown mechanism cancerous cells use to break through the basement membrane, allowing the tumor to become invasive.
MTM alumna and founder of startup Respira Labs Maria Artunduaga is featured in the Innovator Spotlight on VentureWell! She invented a device that continuously monitors patients’ lung function and collects lifestyle and other medical data to improve management of Chronic Obstructive Pulmonary Disease (COPD).
Using a massive set of 244,000 synthetic sequence experiments, Adam Arkin and his collaborators disentangled some of the complex determinants for how bacterial genes are translated. Published today in Nature Biotechnology, their work has made it possible to identify general rules for optimizing protein expression, a fundamental step in understanding living systems, and takes another step toward the efficient design of engineered bacterial gene expression systems.